Cofoe Medical Technology Co.,Ltd. (SHE:301087)
China · Delayed Price · Currency is CNY 56.23
-0.06 (-0.11%)
At close: Mar 31, 2026
Cofoe Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 371.61 | 311.75 | 254.28 | 301.68 | 428.86 |
Depreciation & Amortization | 181.93 | 161.76 | 136.21 | 99.67 | 65.28 |
Other Amortization | 26.1 | 19.48 | 22.61 | 25.21 | 19.06 |
Loss (Gain) From Sale of Assets | 1.37 | -5.88 | -4.59 | -6.47 | -0.14 |
Asset Writedown & Restructuring Costs | -0.18 | 2.32 | 2.24 | 35.29 | 0.05 |
Loss (Gain) From Sale of Investments | -65.69 | -21.75 | -46.3 | -61.31 | -6.02 |
Provision & Write-off of Bad Debts | -0.02 | 5.23 | -0.59 | 14.37 | 10.78 |
Other Operating Activities | 52.76 | 44.41 | 60.12 | 49.71 | 25.28 |
Change in Accounts Receivable | -20.77 | 142.36 | 140.46 | -441.79 | -263.09 |
Change in Inventory | 34.11 | -54.49 | -155.96 | -76.73 | -61.89 |
Change in Accounts Payable | 85.63 | 53.28 | -8.54 | 137.53 | 26.48 |
Change in Other Net Operating Assets | 31.7 | 15.8 | -1.81 | 27.63 | -3.7 |
Operating Cash Flow | 695.73 | 663.39 | 393.82 | 98.91 | 239.99 |
Operating Cash Flow Growth | 4.87% | 68.45% | 298.16% | -58.78% | -51.59% |
Capital Expenditures | -178.1 | -120.5 | -373.22 | -639.79 | -513.24 |
Sale of Property, Plant & Equipment | 18.2 | 1.32 | 1.21 | 1.25 | 0.04 |
Cash Acquisitions | -133.13 | -61.85 | -12.49 | -243.8 | -37.88 |
Divestitures | 6.86 | - | 19.51 | - | - |
Investment in Securities | 177.97 | -565.85 | 265.75 | 281.99 | -1,529 |
Other Investing Activities | 39.23 | 15.91 | 53.57 | 63.26 | 0.05 |
Investing Cash Flow | -68.96 | -730.97 | -45.67 | -537.09 | -2,080 |
Long-Term Debt Issued | 1,156 | 750.35 | 543.26 | 611.98 | 141.73 |
Total Debt Issued | 1,156 | 750.35 | 543.26 | 611.98 | 141.73 |
Long-Term Debt Repaid | -1,321 | -527.54 | -426 | -442.98 | -409.06 |
Total Debt Repaid | -1,321 | -527.54 | -426 | -442.98 | -409.06 |
Net Debt Issued (Repaid) | -164.27 | 222.81 | 117.26 | 169 | -267.33 |
Issuance of Common Stock | 23.86 | - | 23.35 | 16.34 | 3,540 |
Repurchase of Common Stock | -5.5 | -54.47 | -156.32 | - | - |
Common Dividends Paid | -371.78 | -374.49 | -249.91 | -259.6 | -2.7 |
Other Financing Activities | 48.94 | -28.09 | -12.03 | -54.72 | -0.57 |
Financing Cash Flow | -468.75 | -234.24 | -277.66 | -128.98 | 3,269 |
Foreign Exchange Rate Adjustments | -3.43 | 0.59 | 0.18 | 0.24 | -0.03 |
Net Cash Flow | 154.59 | -301.23 | 70.67 | -566.92 | 1,429 |
Free Cash Flow | 517.63 | 542.9 | 20.6 | -540.87 | -273.25 |
Free Cash Flow Growth | -4.65% | 2535.66% | - | - | - |
Free Cash Flow Margin | 15.28% | 18.20% | 0.72% | -18.17% | -12.01% |
Free Cash Flow Per Share | 2.52 | 2.64 | 0.10 | -2.60 | -1.66 |
Cash Interest Paid | 3.16 | 2.38 | 1.8 | - | - |
Cash Income Tax Paid | 245.84 | 141.62 | 200.31 | 113.88 | 165.39 |
Levered Free Cash Flow | 338.91 | 407.11 | -218.22 | -560.38 | -369.44 |
Unlevered Free Cash Flow | 348.95 | 418.31 | -209.78 | -553.6 | -365.18 |
Change in Working Capital | 127.84 | 146.06 | -30.16 | -359.22 | -303.14 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.